Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids

Thrombosis and Haemostasis

Volumn 85, Issue 6, 2001, Pages 966-974

  Tomer, A ^a   Kasey, S ^a   Connor, W E ^a   Clark, S ^a   Harker, L A ^a   Eckman, J R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

N 3 fatty acids; Sickle cell; Thrombosis

Indexed keywords

ALBUMIN; ANTIPLASMIN; ASPARTATE AMINOTRANSFERASE; BETA THROMBOGLOBULIN; BILIRUBIN; CHOLESTEROL; CREATININE; D DIMER; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; LACTATE DEHYDROGENASE; LIPOCORTIN 5; MEMBRANE PHOSPHOLIPID; MENHADEN OIL; NITROGEN; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PADGEM PROTEIN; PEPTIDE FRAGMENT; PLASMIN; PROTHROMBIN; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE FACTOR 4; UREA;

ADULT; ARTICLE; BINDING SITE; BLEEDING DISORDER; BLOOD ANALYSIS; BLOOD CLOTTING; CELL LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEX FORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DISEASE MARKER; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ERYTHROCYTE MEMBRANE; FATTY ACID BLOOD LEVEL; FLOW CYTOMETRY; GASTROINTESTINAL SYMPTOM; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; METABOLIC INHIBITION; MORBIDITY; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SICKLE CELL ANEMIA; THROMBOCYTE; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT OUTCOME;

EID: 0034972252     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615948     Document Type: Article

References (77)

1. Pathology of sickle cell anemia
2. Vascular occlusive mechanisms in sickle cell disease
3. Vascular occlusion in sickle cell disease: Current concepts and unanswered questions
4. Coagulation changes during the steady state in homozygous sickle-cell disease in Jamaica
5. Role of coagulation system in pathophysiology of sickle cell disease
6. Is sickle cell crisis a thrombotic event?
7. Fragment d-dimer levels: An objective marker of vaso-occlusive crisis and other complications of sickle cell disease
8. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients
9. Elevated prothrombin F1.2 fragment in sickle cell disease: Further evidence for activation of coagulation in the steady state
10. Serial changes in coagulation and viscosity during sickle-cell crisis
11. Hemostatic alterations accompanying sickle cell pain crises
12. Elevated plasma levels of fibrinopeptide A during sickle cell anemia pain crisis - Evidence for intravascular coagulation
13. Defective release of tissue plasminogen activator in patients with sickle cell anemia
14. Platelet function and survival in sickle cell disease
15. Platelet function in sickle cell anemia
16. Abnormalities of platelet aggregation in the vaso-occlusive crisis of sickle-cell anemia
17. Abnormalities of platelet aggregation in sickle cell disease
18. Evidence against enhanced platelet activity in sickle cell anaemia
19. Thrombosis in sickle cell disease
20. Molecular basis of sickle cell-endothelial interactions
21. Fish oil inhibits development of atherosclerosis in rhesus monkeys
22. The effect of dietary omega-3 fatty acids on platelet composition and function in man: A prospective, controlled study
23. Cod-liver oil in the prevention of intimal hyperplasia in autogenous vein grafts used for arterial bypass
24. Does platelet aggregation play a role in the reduction in localized intimal proliferation in normolipidemic pigs with fixed coronary artery stenosis fed dietary fish oil?
25. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids
26. Usefulness of fish oil supplements in preventing clinical evidence of restenosis after percutaneous transluminal coronary angioplasty
27. Double-blind randomized controlled trial of fish oil supplements in the prevention of restenosis after coronary angioplasty
28. Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty
29. Fourth ACCP Consensus Conference on Antithrombotic Therapy
30. Collaborative overview of randomized trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
31. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of aeschmia
32. Long-term anticoagulation in sickle-cell disease
33. Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises
34. Trial of low doses of aspirin as prophylaxis in sickle cell disease
35. Treatment of sickle cell diseases with aspirin
36. A double-blind trial of ticlopidine in sickle cell disease
37. Therapeutic effect of aspirin in sickle cell anaemia
38. Coagulation changes during the steady state in homozygous sickle-cell disease in Jamaica
39. Ticlopidine: An updated review of its pharmacology and therapeutic use in platelet-dependent disorders
40. Antithrombotic strategies targeting thrombin activities, thrombin receptors and thrombin generation
41. Experimental strategies for assessing antithrombotic benefits and hemorrhagic risks of novel antithrombotic agents
42. Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates
43. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?
44. Fish oil and vascular disease
45. Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis
46. Inhibition of atherosclerosis by codliver oil in a hyperlipidemic swine model
47. Vascular prostacyclin is increased in patients ingesting omega-3 polyunsaturated fatty acids before coronary artery bypass graft surgery
48. The role of n-3 fatty acids in prophylaxis and treatment of occlusive vascular disease
49. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function
50. The effects of olive oil, hydrogenated palm oil, and n-3 fatty acid-enriched diets on megakaryocytes and platelets
51. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection
52. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry
53. Studies with a monoclonal antibody against activated platelets: Evidence that a secreted 53,000 molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation
54. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane; studies in Scott syndrome: An isolated defect in platelet procoagulant activity
55. Binding of annexin V/placental anticoagulant protein I to platelets
56. Platelet procoagulant activity: Physiological significance and mechanisms of exposure
57. Composition and biosynthesis of sterols in selected marine phytoplankton
58. Eskimo plasma constituents, dihomo-gamma-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid inhibit the release of atherogenic mitogens
59. Dietary eicosapentaenoic acid and docosahexaenoic acid from fish oil. Their incorporation into advanced human atherosclerotic plaques
60. Randomised trial of fish oil for prevention of restenosis after coronary angioplasty
61. Effects of changes in fat, fish, and fibre intakes on death and myocardial infarction: Diet and reinfarction trial (DART)
62. The reappraisal of dilute tissue thromboplastin inhibition test in the diagnosis of lupus anticoagulant
63. Congenital severe protein C deficiency in adults
64. Editor's commentary: The role of n-3 fatty acids in prophylaxis and treatment of occlusive vascular disease
65. Prophylaxis of atherosclerosis with marine omega-fatty acids: A comprehensive strategy
66. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell demormability in healthy human subjects
67. Membrane lipid composition and cellular function
68. Favorable effects of dietary fish oil on capillary perfusion homogeneity after ischaemia and reperfusion
69. Evaluation of an automated prothrombin assay using a chromogenic substrate
70. Dietary fish oil reduces leukocyte/endothelium interaction following systemic administration of oxidatively low density lipoprotein
71. Dietary fish oil blocks the microcirculatory manifestations of ischemia-reperfusion injury in striated muscle in hamsters
72. Platelet activation during pain crisis in sickle cell anemia patients
73. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease
74. Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double-blind, controlled study
75. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study